- Preview Available
- Scholarly Journal
The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells
Kasman, L; Lu P; Voelkel-Johnson, C.
Cancer Gene Therapy; San Diego Vol. 14, Iss. 3, (Mar 2007): 327-334.
DOI:10.1038/sj.cgt.7701017
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.